Eagle Pharmaceuticals Share Holder Equity 2013-2023 | EGRX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Eagle Pharmaceuticals share holder equity from 2013 to 2023. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Eagle Pharmaceuticals share holder equity from 2013 to 2023. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$196.7B
Stryker (SYK)	$142.8B
Boston Scientific (BSX)	$132.8B
EssilorLuxottica (ESLOY)	$110.9B
Medtronic (MDT)	$105.8B
Haleon (HLN)	$44.2B
Lonza Group Ag (LZAGY)	$43.1B
GE HealthCare Technologies (GEHC)	$37.1B
ResMed (RMD)	$35B
Terumo (TRUMY)	$29.6B
Koninklijke Philips (PHG)	$24.2B
Zimmer Biomet Holdings (ZBH)	$21.2B
Insulet (PODD)	$18.9B
Baxter (BAX)	$15.5B
Smith & Nephew SNATS (SNN)	$11.2B
BellRing Brands (BRBR)	$10B
Bio-Rad Laboratories (BIO)	$9.4B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$6.5B
Haemonetics (HAE)	$4.1B
Prestige Consumer Healthcare (PBH)	$4.1B
ICU Medical (ICUI)	$4B
Perrigo (PRGO)	$3.7B
Envista Holdings (NVST)	$3.4B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.9B
QuidelOrtho (QDEL)	$2.8B
Neogen (NEOG)	$2.6B
LeMaitre Vascular (LMAT)	$2.3B
Green Thumb Industries (GTBIF)	$1.7B